Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin

This review is devoted to pharmacological characteristics, action mechanisms, hypolipidemic activity, and pleiotropic effects of a new hypolipidemic medication – ezetimibe, inhibiting intestinal cholesterol absorption. The combination of ezetimibe with other hypolipidemic drugs (statins, fibrates, b...

Full description

Bibliographic Details
Main Author: D. M. Aronov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2005-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/993
_version_ 1827064142454849536
author D. M. Aronov
author_facet D. M. Aronov
author_sort D. M. Aronov
collection DOAJ
description This review is devoted to pharmacological characteristics, action mechanisms, hypolipidemic activity, and pleiotropic effects of a new hypolipidemic medication – ezetimibe, inhibiting intestinal cholesterol absorption. The combination of ezetimibe with other hypolipidemic drugs (statins, fibrates, bile acid sequestrants) is described in detail. Initial doses of various statins, together with one tablet (10 mg) of ezetimibe, reduce low-density cholesterol level as effectively as maximal statin doses.
first_indexed 2024-04-10T03:41:18Z
format Article
id doaj.art-169ba388308d4762bc0734e86fe19a8a
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2025-03-19T22:42:27Z
publishDate 2005-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-169ba388308d4762bc0734e86fe19a8a2024-10-17T12:21:23Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252005-08-014491100707Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatinD. M. Aronov0State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, MoscowThis review is devoted to pharmacological characteristics, action mechanisms, hypolipidemic activity, and pleiotropic effects of a new hypolipidemic medication – ezetimibe, inhibiting intestinal cholesterol absorption. The combination of ezetimibe with other hypolipidemic drugs (statins, fibrates, bile acid sequestrants) is described in detail. Initial doses of various statins, together with one tablet (10 mg) of ezetimibe, reduce low-density cholesterol level as effectively as maximal statin doses.https://cardiovascular.elpub.ru/jour/article/view/993cholesterol absorption inhibitioncombined hypolipidemic therapyezetimibestatins
spellingShingle D. M. Aronov
Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
Кардиоваскулярная терапия и профилактика
cholesterol absorption inhibition
combined hypolipidemic therapy
ezetimibe
statins
title Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
title_full Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
title_fullStr Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
title_full_unstemmed Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
title_short Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
title_sort simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
topic cholesterol absorption inhibition
combined hypolipidemic therapy
ezetimibe
statins
url https://cardiovascular.elpub.ru/jour/article/view/993
work_keys_str_mv AT dmaronov simultaneousinhibitionofcholesterolabsorptionandsynthesisincombinedtherapywithezetimibeandsimvastatin